Skip to main content
Have a personal or library account? Click to login
Plasma Neutrophil Gelatinase Associated Lipocalin (NGAL) – Early Biomarker for Acute Kidney Injury in Critically Ill Patients Cover

Plasma Neutrophil Gelatinase Associated Lipocalin (NGAL) – Early Biomarker for Acute Kidney Injury in Critically Ill Patients

Open Access
|Nov 2015

References

  1. 1. Singbartl K, Kellum JA. AKI in the ICU: Definition, Epidemiology, Risk Stratification, and Outcomes. Kidney Int. 2012;81(9):819-25.
  2. 2. Cruz DN, Cal M, Garzotto M. Plasma neutrophil gelatinaseassociated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med. 2010; 36:444-51.
  3. 3. Fatemeh G, Faranak K, Esmat G, Rahimipour A, Houshang A, Malihe N. Assessment of Neutrophil gelatinase-associated lipocalin (NGAL) as an early biomarker for detection of renal impairment in hypertensive patients. Journal of Paramedical Sciences. 2014;5:63-6.
  4. 4. Flower DR, North AC, Sansom CE. The lipocalin protein family: structural and sequence overview. Biochim Biophys Acta. 2000;1482:9-24.
  5. 5. Bolignano D, Donato V, Coppolino G, et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Marker of Kidney Damage.American Journal of Kidney Diseases. 2008;52:595-605.
  6. 6. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;268:10425-32.
  7. 7. Devarajan P: Emerging Biomarkers of Acute Kidney Injury. In Ronco C, Bellomo R, Kellum JA: Acute Kidney Injury. ContribNephrol, vol 156. Basel:Karger. 2007, pp 203-12.
  8. 8. K Mori, K Nakao. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney International. 2007;71:967-70.
  9. 9. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
  10. 10. Prowle JR, Leitch A, Kirwan CJ, Forni LG. Positive fluid balance and AKI diagnosis: assessing the extent and duration of ‘creatinine dilution’. Intensive Care Med. 2015;41:160-1.
  11. 11. Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): A new marker of kidney disease. Scand J Clin Lab Invest Suppl. 2008;241:89-94.
  12. 12. Perry TE, Muehlschlegel JD, Liu KY. Plasma Neutrophil Gelatinase-Associated Lipocalin and Acute Postoperative Kidney Injury in Adult Cardiac Surgical Patients. AnesthAnalg. 2010;110:1541-7.
  13. 13. Fielitz AH, Bellomo R, Devarajan P, et al. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant. 2009;24:3349-54.
  14. 14. Bachorzewska GH, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S. Neutrophil gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol. 2006;26:287-92.
  15. 15. Malyszko J, Bachorzewska GH, Malyszko JS, Dobrzycki S. Could NGAL predict renal function after percutaneous coronary interventions? J Am SocNephrol. 2006;17:406A.
  16. 16. Parikh CR, Jani A, Mishra J et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006;6:1639-45.
  17. 17. Mishra J, Ma Q, Kelly C, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol. 2006;21:856-63.
  18. 18. Mitsnefes M, Kathman T, Mishra J, et al. Serum NGAL as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol. 2007;22:101-8.
  19. 19. Bolignano D, Coppolino G, Campo S, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transpl. 2008;23:414-6.
  20. 20. Bolignano D, Coppolino G, Campo S, et al. Neutrophil gelatinase associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am J Nephrol. 2007;27:373-8.
  21. 21. Legrand M, Jacquemod A, Gayat E. Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria. Intensive Care Med. 2015;41:68-76.
  22. 22. Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clinical Journal of the American Society of Nephrology. 2009;4:337-44.
  23. 23. Haase M, Bellomo R, Fielitz AH. Neutrophil gelatinaseassociated lipocalin: a superior biomarker for detection of subclinical acute kidney injury and poor prognosis. Biomarkers Med. 2011;5(4):415-7.
  24. 24. Devarajan P. Biomarkers for the early detection of acute kidney injury. Current Opinion in Pediatrics. 2011;23:194-200.
  25. 25. Poniatowski B, Malyszko J, Bachorzewska GH, Malyszko JS, Dobrzycki S. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease. Kidney Blood Press Res. 2009;32:77-80.
  26. 26. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut. 1996;38:414-20.
DOI: https://doi.org/10.1515/jccm-2015-0023 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 154 - 161
Submitted on: May 2, 2015
Accepted on: Jul 5, 2015
Published online: Nov 10, 2015
Published in print: Oct 1, 2015
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2015 Grigorescu Bianca, Fodor Raluca, Mihaly Veres, Monica Orlandea, Judita Badea, Katalin Hlavathy, Adrian Cioc, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.